GlassScriptPhysician profile
Heather R Jereb
NPI 1720390511
$1,294.97
in general payments reported to CMS, 2019-2025
19 companies · $60.56 in 2025
The $60.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $34.45 · 2021: $233 · 2022: $278 · 2023: $214 · 2024: $130 · 2025: $60.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $352.81 | 2019-2023 | |
| Hologic Sales and Service, LLC | $300.26 | 2019-2025 | Coolseal Generator, Myosure Tissue Removal Device, Novasure |
| Aspira Women'S Health INC | $159.90 | 2022-2023 | Ova1 |
| Astellas Pharma US INC | $85.50 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $84.76 | 2019-2025 | |
| Amag Pharmaceuticals, INC. | $48.25 | 2019 | |
| Daiichi Sankyo INC. | $33.04 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $28.56 | 2023 | Myfembree |
| Biogen, INC. | $26.66 | 2024 | |
| Merck Sharp & Dohme LLC | $23.97 | 2025 | Gardasil 9 |
| Myovant Sciences INC. | $20.49 | 2021 | |
| Medtronic, INC. | $19.85 | 2023 | Truclear |
| Pacira Pharmaceuticals Incorporated | $19.17 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.07 | 2019 | |
| Coopersurgical, INC. | $15.77 | 2023 | Paragard T 380a |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $15.72 | 2022 | |
| Ibsa Pharma INC. | $14.67 | 2022 | |
| Organon LLC | $14.44 | 2023 | Nexplanon |
| Mallinckrodt Enterprises LLC | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Jereb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.